Clinical Trials Logo

Citation(s)

A Phase 2a, Open-label, Multiple Dose, Safety, Pharmacokinetic and Biomarker Study of PTl-125 in Mild-to-moderate Alzheimer's Disease Patients

Details for clinical trial NCT03748706